Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Brain Cancer Market Forecast: Value Set To Climb From $3.6 Billion To $4.76 Billion
The brain cancer market has experienced substantial expansion in recent years. Projections indicate an increase from $3.35 billion in 2025 to $3.60 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. Historically, this expansion can be linked to factors such as a rise in brain cancer cases, increased use of neuroimaging techniques, a heightened need for chemotherapy and radiotherapy, broadened availability of specialized cancer treatment facilities, and greater healthcare spending.
The brain cancer market is projected to undergo significant expansion in the coming years. It is forecast to achieve a size of $4.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This growth over the forecast period is attributable to an increasing demand for targeted therapies, the rising adoption of immunotherapies, a wider application of minimally invasive neurosurgeries, an intensified focus on early diagnosis, and increasing investment in oncology infrastructure. Prominent trends for this period include advancements in AI-based diagnostic tools, the development of personalized medicine solutions, innovations in immunotherapy combinations, progress in liquid biopsy technologies, and continued research and development in high-precision imaging systems.
Get A Free Sample Report With In-Depth Market Insights:
Brain Cancer Market Industry Drivers: What’s Behind The Revenue Growth?
The escalating occurrence of neurological tumors is projected to advance the expansion of the brain cancer market in the future. Neurological tumors are characterized as unusual and frequently malignant formations within the brain or central nervous system, which hinder neurological function and demand elaborate clinical management. The incidence of neurological tumors is growing due to demographic transformations, including an aging and increasing population, as older individuals face a higher risk of developing brain cancers. The brain cancer market addresses neurological tumor prevalence by broadening diagnostic, treatment, and care offerings to cater to the clinical requirements of the expanding patient demographic. For example, in January 2025, the American Cancer Society, a US-based non-profit organization, anticipates approximately 14,040 new cases of brain tumors and other nervous system cancers among males and 10,780 among females in 2025, with an estimated 18,330 total deaths. Hence, the rising prevalence of neurological tumors is a primary force behind the growth of the brain cancer market.
Brain Cancer Market Segment Analysis: What Are The Core Market Categories?
The brain cancer market covered in this report is segmented –
1) By Product Type: Therapeutic Treatments, Diagnostic Imaging, Surgical Devices, Supportive Care Products
2) By Surgical Treatment: Tumor Resection, Minimally Invasive Surgery, Stereotactic Surgery
3) By Diagnosis: Imaging Techniques, Biopsy, Molecular Testing, Genetic Testing
4) By Supportive Care: Rehabilitation, Palliative Care, Counseling, Follow-Up Care
5) By End User: Hospitals, Specialty Clinics, Research Institutes
Subsegments:
1) By Therapeutic Treatments: Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Agents, Radiation Therapy Products, Hormone Therapy Products, Tumor Treating Fields Devices
2) By Diagnostic Imaging: Magnetic Resonance Imaging Systems, Computed Tomography Scanners, Positron Emission Tomography Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems
3) By Surgical Devices: Neurosurgical Navigation Systems, Craniotomy Instruments, Neuroendoscopy Devices, Surgical Microscopes, Stereotactic Surgical Equipment
4) By Supportive Care Products: Pain Management Medications, Anti Nausea Medications, Nutritional Support Products, Rehabilitation Equipment, Symptom Management Products
#Brain Cancer Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies active in the brain cancer market are concentrating on developing sophisticated diagnostic and imaging instruments, such as AI-powered MRI segmentation platforms, to enhance clinical decision-making and treatment strategies. These AI-driven MRI segmentation platforms are software systems that utilize artificial intelligence to automatically identify and delineate anatomical structures or lesions on MRI scans, thereby supporting faster and more consistent diagnosis and treatment planning. For instance, in July 2025, Cortechs.ai, a US-based medical imaging software company, launched NeuroQuant Brain Tumor, featuring enhanced AI-driven MRI segmentation models. This offers automated volumetric quantification and metastasis/meningioma segmentation, which improves radiologist efficiency and diagnostic consistency compared to manual interpretation, with cloud-based deployment and PACS integration for rapid scalability. By offering objective segmentations and volumetric reports, this innovative technology boosts the efficiency and standardization for radiologists, neurosurgeons, and neuro-oncologists, while saving time and improving clinical consistency and diagnostic confidence. Clinicians can directly foster improved patient outcomes by tracking tumor changes over time and gaining vital insights into therapy response and disease progression.
Brain Cancer Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the brain cancer market are Providence Health & Services, Ascension Health, Trinity Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Cleveland Clinic, The Mount Sinai Hospital, The University of Texas MD Anderson Cancer Center, CommonSpirit Health, City of Hope National Medical Center, Stanford Health Care, Apollo Hospitals Enterprise Limited, Elekta AB, H. Lee Moffitt Cancer Center & Research Institute Inc., Roswell Park Comprehensive Cancer Center, Fred Hutchinson Cancer Center, Fortis Healthcare Limited, Dana-Farber Cancer Institute Inc., The Johns Hopkins Hospital, The Regents of the University of California
View The Full Brain Cancer Market Report:
Brain Cancer Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the brain cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
